Selection of Fluorescent, Bioluminescent, and Radioactive Tracers to Accurately Reflect Extracellular Vesicle Biodistribution <i>in Vivo</i>
Elisa Lázaro‐Ibáñez(AstraZeneca (Sweden)), Niek Dekker(AstraZeneca (Sweden)), Janusz Rak(McGill University Health Centre), Farid N. Faruqu(King's College London), Amer F. Saleh(AstraZeneca (United Kingdom)), Khuloud T. Al‐Jamal(King's College London), Andreia Silva(AstraZeneca (Sweden)), Julie Wang(Shanghai Jiao Tong University)
Cited by 263
Related Papers
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis
|Journal of Allergy and Clinical Immunology|2020|676
Drug allergy: A 2022 practice parameter update
|Journal of Allergy and Clinical Immunology|2022|504
Rhinitis 2020: A practice parameter update
|Journal of Allergy and Clinical Immunology|2020|399